Press Releases
IQST - IQSTEL Announces Strategic Digital Health Partnership and Investor Conference Call to Discuss Q4 & FY 2025 Results
Company to Enter Multi-Billion Dollar Digital Health Market NEW YORK, April 7, 2026 /PRNewswire/ -- IQSTEL Inc. (NASDAQ: IQST), a rapidly growing global telecommunications and technology company, today announced the signing of a Non-Binding Commercial Memorandum of Understanding (MOU) with a digital health technology company to establish a strategic partnership in the Digital Health sector, alongside hosting its investor conference call to discuss financial results for the fourth quarter and full year ended December 31, 2025. Leandro Iglesias, President & CEO of IQSTEL, commented: "This partnership represents a major milestone in our strategy to transform IQSTEL into a high-tech, high-margin platform company...
Vision Marine Technologies Expands Commercial Operator Channel with Initial Hospitality Fleet Deployment in Michigan
Commercial Platform Expansion MONTREAL, April 7, 2026 /PRNewswire/ -- Vision Marine Technologies Inc. (NASDAQ: VMAR) ("Vision Marine" or the "Company"), a vertically integrated marine company combining proprietary electric propulsion technology with a multi-location retail network, today announced the sale of an initial four Fantail 217 electric boats to Keweenaw Waters Resort, a waterfront hospitality destination located on the Keweenaw Peninsula along Lake Superior in Michigan. While the initial deployment consists of four units, the transaction reflects a broader commercial expansion strategy focused on supplying hospitality operators, resorts, and fleet managers in addition to traditional retail consumers...
W. P. Carey to Release First Quarter 2026 Financial Results on Tuesday, April 28, 2026
Conference Call Scheduled for Wednesday, April 29, 2026 at 11:00 a.m. Eastern Time NEW YORK, April 7, 2026 /PRNewswire/ -- W.
Anavex Life Sciences to Present at the 25th Annual Needham Virtual Healthcare Conference
NEW YORK, April 07, 2026 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders, today announced that it will present at the 25th Annual Needham Virtual Healthcare Conference, April 13 – 16, 2026. President and Chief Executive Officer Christopher U. Missling, PhD and his management team will present the Company scheduled at 1:30 PM (ET) on Tuesday, April 14th, 2026...
Marvel Biosciences Secures Financial and Strategic Investment with 5 Horizon Ventures
Marvel announces financial and strategic backing from 5 Horizons Ventures to support its upcoming Phase 1 clinical trial of patented lead asset MB-204
Creative Realities, Inc. Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Conference Call Information
LOUISVILLE, Ky., April 07, 2026 (GLOBE NEWSWIRE) -- Creative Realities, Inc. ("Creative Realities," "CRI," or the "Company") (NASDAQ: CREX), a leading provider of digital signage, media and AdTech solutions, announced today that it will release its financial results for the quarter and full year ended December 31, 2025 before the market opens on Tuesday, April 14, 2026. A conference call to review the results is scheduled for Tuesday, April 14, 2026, at 9:00 am Eastern Time, which will include prepared remarks and materials from management followed by a live Q&A. The call will be hosted by Rick Mills, Chief Executive Officer, George Sautter, Chief Strategy Officer, and Tamra Koshewa, Chief Financial Officer...
Plus Therapeutics Receives AMA PLA Code for CNSide® CSF Tumor Cell Enumeration Test, Advancing Reimbursement and U.S. Commercial Adoption
New dedicated billing code facilitates payer reimbursement, supports clinician adoptions, and enables national utilization tracking New dedicated billing code facilitates payer reimbursement, supports clinician adoptions, and enables national utilization tracking
Cognition Therapeutics to Present at Needham Virtual Healthcare Conference
PURCHASE, N.Y., April 07, 2026 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (Nasdaq: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, announced that the Company's president and CEO, Lisa Ricciardi intends to present at the 25th Annual Needham Virtual Healthcare Conference on Monday, April 13th at 3:00 p.m. Eastern Time. During her presentation, Ms. Ricciardi will provide an update on progress of the Company's development programs for Alzheimer's disease and dementia with Lewy bodies (DLB)...
Palvella Therapeutics Appoints Accomplished Commercial Leader Kent Taylor as Senior Vice President of Sales
Mr. Taylor brings a strong track record launching multiple high-profile therapies, most recently serving as Senior Vice President, Sales at Arcutis Biotherapeutics (Nasdaq: ARQT), where he led U.S. sales efforts for ZORYVE, a next-generation topical PDE4 inhibitor; previously, he held leadership roles at Incyte (Nasdaq: INCY) supporting the launch of OPZELURA
CervoMed to Provide Neflamapimod Clinical Program Update and Participate in a Panel on Biomarkers at 2026 Lewy Body Dementia Association Annual Meeting
Update will include new MRI analyses from the Phase 2b RewinD-LB clinical trial, status of global regulatory discussions, and finalized Phase 3 trial design
NervGen Pharma Announces Successful End-of-Phase 2 Meeting and FDA Alignment on RESTORE, a Phase 3 Registrational Study of NVG-291 for Chronic Tetraplegia
VANCOUVER, British Columbia, April 07, 2026 (GLOBE NEWSWIRE) -- NervGen Pharma Corp. (“NervGen” or the “Company") (NASDAQ: NGEN), a clinical-stage biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury (SCI) and other neurotraumatic and neurologic conditions, today announced the completion of a successful End-of-Phase 2 (EOP2) meeting with the U.S. Food and Drug Administration (FDA) and alignment on RESTORE, the Company's Phase 3 registrational study designed to evaluate NVG-291 for the treatment of chronic tetraplegia...
Akamai Technologies To Hold First Quarter 2026 Investor Conference Call On Thursday, May 7, at 4:30 PM ET
CAMBRIDGE, Mass., April 07, 2026 (GLOBE NEWSWIRE) -- Akamai Technologies , Inc. (NASDAQ: AKAM), the cybersecurity and cloud computing company that powers business online, announced today that the company will hold a conference call for investors on Thursday, May 7, 2026, at 4:30 p.m.
Revival Gold Drills 2.8 g/t gold over 74 meters Including 8.0 g/t over 12 meters at the Mercur Gold Project in Utah
TORONTO, ON / ACCESS Newswire / April 7, 2026 / Revival Gold Inc. (TSXV:RVG)(OTCQX:RVLGF) ("Revival Gold" or the "Company") is pleased to provide final results from the 2025 drilling program at the Company's Mercur Gold Project ("Mercur" or the "Project") located in Utah. Highlights Highlight intercepts at South Mercur include: 2.8 g/T gold over 74 meters width at 91 meters downhole in RMC25-031; including 8.0 g/T gold over 12 meters width at 130 meters downhole; 1.1 g/T gold over 84 meters width at 14 meters downhole in RMC25-032; and 1.0 g/T gold over 82 meters width at 13 meters downhole in RMC25-033...
Weight Watchers Appoints Lisa Gavales and Sue Gove to Board of Directors
New, Independent Directors Bring Deep Consumer, Digital and Turnaround Expertise to Support Strategic Transformation New, Independent Directors Bring Deep Consumer, Digital and Turnaround Expertise to Support Strategic Transformation
Bread Financial Schedules First Quarter 2026 Earnings Conference Call for Apr. 23
COLUMBUS, Ohio, April 07, 2026 (GLOBE NEWSWIRE) -- Bread Financial Holdings, Inc. (NYSE: BFH), a tech-forward financial services company that provides simple, personalized payment, lending, and saving solutions will host a conference call on Thursday, Apr. 23, 2026, at 8:30 a.m. ET to discuss the company's first quarter 2026 results...
Beyond Minerals Completes Final Option Payments to Acquire 100% Interest in Ear Falls Project and Files Amended Offering Document for LIFE Offering
Winnipeg, Manitoba--(Newsfile Corp. - April 7, 2026) - Beyond Minerals Inc. (formerly Beyond Lithium Inc.) (CSE: BY) (OTCQB: BYDMF) (the "Company" or "Beyond Minerals") is pleased to announce it has made the final payments under its mineral property option agreement with Bounty Gold Corp. (the "Optionor") dated March 30, 2023, as amended (the "Option Agreement"), to acquire a 100% undivided interest in the Ear Falls spodumene-bearing pegmatite exploration project, located near the town of Ear Falls, in the province of Ontario (the "Ear Falls Project"). The final payments made to the Optionor under the Option Agreement consisted of 78,800 common shares of the Company and C$29,500 in cash (the "Final Payments")...
Red Light Holland Reports Continued Expansion of Filament Health's PEX010 Clinical Network with New License Agreements and Research Shipments
Three new license agreements signed and two research shipments completed in March 2026, spanning institutions in Australia, the United Kingdom, and Canada Toronto, Ontario--(Newsfile Corp. - April 7, 2026) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light" or the "Company") today announced that Filament Health Corp. ("Filament") signed three new license agreements and completed two research shipments during March 2026, further expanding the global clinical network for PEX010, Filament's patented botanical psilocybin drug candidate. Red Light recently announced a definitive arrangement agreement to acquire Filament Health Corp., including its portfolio of 76 issued patents across 15 patent families and its lead drug candidate, PEX010...
Zimmer Biomet Appoints Dr. Jonathan M. Vigdorchik as Chief Science, Technology and Medical Affairs Officer
Experienced orthopedic surgeon from the Hospital for Special Surgery, innovator and former Chief Medical Technology Advisor joins company in an elevated capacity WARSAW, Ind., April 7, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced the appointment of Jonathan M...
Golden Rapture Identifies Many Strong Magnetic Anomalies at Its Northern Queen Mine Project Directly Adjacent to Nexgold and Dryden Gold
Edmonton, Alberta--(Newsfile Corp. - April 7, 2026) - Golden Rapture Mining Corporation (CSE: GLDR) is pleased to announce the results of the recently completed low-altitude, high-resolution drone magnetic survey of its 100% owned Northern Queen Mine Property, Dryden Area, Ontario. The (UAV) airborne magnetics survey was conducted by Rosor Exploration of Burlington, Ontario...
Neuroscale AI Joins HPE Unleash AI Partner Program to Bring Signal-Based, Agentic Recruiting to Enterprise AI Deployments
STERLING, Va., April 07, 2026 (GLOBE NEWSWIRE) -- Neuroscale AI, the company behind Arbi, an agentic AI recruiting platform designed to turn talent acquisition into a measurable, repeatable system, today announced it has joined the HPE Unleash AI partner program.
Uniserve Appoints Gautam Lohia as Chief Executive Officer, Bringing Founder-Operator Leadership to Accelerate Digital Infrastructure Strategy
Vancouver, British Columbia--(Newsfile Corp. - April 7, 2026) - Uniserve Communications Corporation (TSXV: USS) (the "Company" or "Uniserve"), a Digital Infrastructure Platform enabling mission-critical connectivity, cloud, managed IT, and AI agent driven services for Canadian businesses, is pleased to announce the appointment of Gautam Lohia, current Chairman of the Board, as Chief Executive Officer of the Company, effective immediately. This appointment represents a strategic inflection point for Uniserve, aligning the Company with founder-led, operator-driven leadership as it accelerates its transformation into a scaled, high-margin digital infrastructure and managed services platform...
Domino's Celebrates New Signature Sauce with Exclusive Access to Cobranded Merchandise from Shinola
Domino's is giving away free Slice Sauce with any online purchase of Handmade Pan or Parmesan Stuffed Crust Pizza now through June 14 ANN ARBOR, Mich., April 7, 2026 /PRNewswire/ -- It's no coincidence that Domino's most indulgent, premium pizzas – Handmade Pan and Parmesan Stuffed Crust – come in black and gold boxes, as elevated pizzas call for elevated boxes...
Natural Grocers® Expands Private-Label Brand With Regenerative Organic Certified® Pasture-Raised Eggs
New offering meets industry-leading standards for soil health, animal welfare, and farmworker fairness LAKEWOOD, Colo., April 7, 2026 /PRNewswire/ -- Natural Grocers, the nation's largest family-operated natural and organic grocery retailer, is introducing Natural Grocers Brand Regenerative Organic Certified Pasture-Raised Eggs, a new private-label offering that reflects the company's longstanding commitment to supporting regenerative agriculture, humane animal care, and small family farmers...
NeoGenomics to Report First Quarter 2026 Financial Results on April 28, 2026
FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced that it will report its first quarter 2026 financial results after the close of the U.S. financial markets on Tuesday, April 28, 2026. Company management will host a webcast and conference call at 4:30 p.m. ET to discuss financial results and recent highlights. Beginning with Q1 2026, NeoGenomics will hold quarterly results calls...
Cosigo Resources Announces Results of Conglomerate Layer Bulk Sample for Gravity Concentration Tests
Victoria, British Columbia--(Newsfile Corp. - April 7, 2026) - Cosigo Resources Ltd. (TSXV: CSG) (OTCQB: COSRF) ("Cosigo" or the "Company"): Conglomerate Bulk Sample from the Chicken Coop Conglomerate Stratigraphic Unit Conglomerate Bulk Sample Preparation Knelson gravity testing was conducted on a composite 60kg sample of the "Chicken Coop" (informal stratigraphic) unit conglomerate from the Taraira project...
IsoEnergy Winter Drilling Intersects Elevated Radioactivity in Multiple Holes, Including 30,050 cps over 1.0 Metre, in a Newly Reinterpreted Fault Zone on the South Trend of the Hurricane Deposit
TORONTO, April 7, 2026 /PRNewswire/ - IsoEnergy Ltd. ("IsoEnergy", or "The Company") (NYSE American: ISOU) (TSX: ISO) is pleased to announce results from its recently completed 2026 winter exploration drilling program at the Larocque East project (the "Project"), home to the high-grade Hurricane deposit ("Hurricane" or the "Deposit"), in the eastern Athabasca Basin, Canada...
Fennec Pharmaceuticals Announces Investigator-Sponsored Study to Be Conducted by University of Arizona Cancer Center
~ University of Arizona Cancer Center Initiating Study to Explore Use of PEDMARK in AYA & Adult Patients with Solid Tumors Receiving Cisplatin ~
San Diego extends partnership with New Flyer through new order for 73 CNG buses
ST. CLOUD, Minn., April 07, 2026 (GLOBE NEWSWIRE) -- (TSX: NFI, OTC: NFYEF, TSX: NFI.DB) NFI Group Inc. (NFI), a leading manufacturer of buses and coaches and a provider of comprehensive aftermarket parts and service solutions, subsidiary New Flyer of America Inc. (New Flyer), today announced that the San Diego Metropolitan Transit System (MTS) has exercised an option to purchase an additional 50 forty-foot and 23 sixty-foot Xcelsior compressed natural gas heavy-duty transit buses. The order comes in the fourth year of a five-year contract originally announced in 2022. This latest purchase, valued at approximately $64 million including 96 equivalent units, was added to NFI's firm backlog for the fourth quarter of 2025...
Radiopharm Theranostics and Siemens Healthineers Sign Clinical Supply Agreement for RAD101 in the U.S.
Data from the interim analysis in Phase 2b trial of RAD101 showed significant and selective tumor uptake in brain metastases, with 90% concordance (Primary Endpoint) with MRI.
AC Immune Announces Amendment to Morphomer ® Tau License and Collaboration Agreement with Lilly
AC Immune Announces Amendment to Morphomer Tau License and Collaboration Agreement with Lilly Amended agreement reflects growing excitement in the field for targeting intracellular Tau and significant progress made with our Morphomer small molecules Investigational New Drug (IND)-enabling studies to commence in H1 2026 Lausanne, Switzerland, April 7, 2026 -- AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company pioneering precision therapeutics for neurodegenerative diseases, today announced an agreement with Eli Lilly and Company (Lilly) to amend their 2018 license and collaboration agreement to research and develop Tau aggregation inhibitor small molecules for the potential treatment of Alzheimer's disease (AD) and other neurodegenerative diseases. The amendment continues the research and collaboration to cover development of new lead Tau Morphomer candidates and potential back-up compounds...
RUA GOLD Reports High-Grade Gold Results from Supreme and Caledonian in the Reefton Goldfield, New Zealand
Vancouver, British Columbia--(Newsfile Corp. - April 7, 2026) - Rua Gold Inc. (TSX: RUA) (NZX: RGI) (OTCQX: NZAUF) (FSE: X9R) ("RUA GOLD" or the "Company") is pleased to provide an update on recent drilling and surface sampling results from its regional exploration program across the Reefton Project on the South Island of New Zealand. Highlights: The Supreme resource, previously explored by OceanaGold as a potential satellite pit to Globe Progress mine, hosts an Inferred Mineral Resource of 1.46Mt @ 1.96g/t, containing 92koz Au(1)...
Toogood Gold Corp. Appoints Lee Hess as Vice President, Exploration
Vancouver, British Columbia--(Newsfile Corp. - April 7, 2026) - Toogood Gold Corp. (TSXV: TGC) (OTCQB: TGGCF) (FSE: D3P) ("Toogood" or the "Company") today announced the appointment of Mr. Lee Hess, M.Sc.
Libra Energy Materials Awarded $200,000 Grant from Ontario Government
Toronto, Ontario--(Newsfile Corp. - April 7, 2026) - Libra Energy Materials Inc. (CSE: LIBR) (OTCQB: LIBRF) (FSE: W0R0) ("Libra" or the "Company"), a leading explorer focused on lithium and other critical energy materials, is pleased to announce it has been awarded CAD $200,000 in non-dilutive grant funding from the Ontario government through the Ontario Junior Exploration Program ("OJEP"). Administered by the Ontario Ministry of Mines, the OJEP grant provides financial assistance to junior exploration companies to offset costs associated with grassroots mineral exploration...
Bitcoin Treasury Corporation Provides March Update on Normal Course Issuer Bid
Toronto, Ontario--(Newsfile Corp. - April 7, 2026) - Bitcoin Treasury Corporation (TSXV: BTCT) (OTCQB: BTCFF) ("Bitcoin Treasury" or the "Company"), a Canadian Bitcoin-native company building shareholder value in Bitcoin, today is providing an update on its previously disclosed Normal Course Issuer Bid ("NCIB") on January 5, 2026. Bitcoin Treasury has purchased and retired 46,500 common shares from March 1, 2026, through to March 31, 2026, at an average price of $4.18 per share...
Gladiator's 2026 Drilling to Commence Mid-April
Vancouver, British Columbia--(Newsfile Corp. - April 7, 2026) - Gladiator Metals Corp. (TSXV: GLAD) (OTCQB: GDTRF) (FSE: ZX7) ("Gladiator" or the "Company") is pleased to announce drilling will soon commence at Cowley and Cub East, with a third rig scheduled to mobilize at the end of April to test Great Southern. HIGHLIGHTS:2026 - Initial 35,000 Metres Planned Cowley resource delineation and extension drilling commencing under Gladiator's Class 3 permit...
Baker Hughes Secures Strategic Gas Technology Order Supporting Argentina's Gas Infrastructure
HOUSTON and LONDON, April 07, 2026 (GLOBE NEWSWIRE) -- Baker Hughes (NASDAQ: BKR), an energy technology company, announced Tuesday it has secured a strategic order from San Matias Pipeline S.A. to supply three gas compression units for a major natural gas pipeline project in Argentina. The order consists of three NovaLT™16 gas turbines equipped with three centrifugal compressors, along with commissioning services, spare parts, special tools, and remote monitoring and diagnostic capabilities. This equipment will be installed at a gas compressor station near Allen, Río Negro, to support the transportation of natural gas from the Vaca Muerta formation to the Gulf of San Matias through a dedicated pipeline, providing feed gas to Southern Energy's two floating LNG vessels...
OKYO Pharma Announces Scientific Advisory Board Meeting and Urcosimod Data Presentation During ASCRS Annual Meeting
LONDON and NEW YORK, April 07, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain (NCP) and for inflammatory eye diseases, today announced that it will hold a key Scientific Advisory Board (SAB) meeting with leading ophthalmology experts during the 2026 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting in Washington, DC. The SAB meeting, scheduled to take place alongside the conference, will bring together prominent corneal and ocular surface disease specialists to review clinical data for the company's lead candidate, urcosimod and provide strategic guidance on the upcoming clinical program...
Precigen Reports 'Robust Uptake' of New Drug for Rare Respiratory Disease; First Quarter Revenue Expected to Top $18 Million
Plans Underway to Expand Use to Pediatrics, Patient Redosing and European Approval Meg Flippin, Benzinga Staff Writer GERMANTOWN, MD / ACCESS Newswire / April 7, 2026 / Precigen Inc. (NASDAQ:PGEN), a commercial-stage biopharmaceutical company developing precision medicines to improve the quality of life for people suffering from recurrent respiratory papillomatosis (RRP) and other diseases, is making progress on that front, announcing it has seen "robust uptake" in usage of PAPZIMEOS (zopapogene imadenovec-drba), since launching the immunotherapy in August 2025. What's more, the company announced that the Centers for Medicare & Medicaid Services (CMS) assigned J-code J3404 to the therapy effective April 1, 2026, which will streamline reimbursement and broaden access to the treatment...
Silver Storm Expands Senior Leadership and Technical Team
TORONTO, ON / ACCESS Newswire / April 7, 2026 / Silver Storm Mining Ltd. ("Silver Storm" or the "Company") (TSXV:SVRS)(OTCQX:SVRSF)(FSE:SVR) is pleased to announce the addition of four experienced mining professionals to its senior leadership team: Fernando Ragone, Chief Financial Officer Arturo Zamudio, General Manager, Mexico Shane Ghouralal, P.Eng...
Enanta Pharmaceuticals to Present Data for Zelicapavir, an Oral, Once-Daily, N-Protein Inhibitor, in Development for the Treatment of Respiratory Syncytial Virus, at ESCMID Global 2026
WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological diseases today announced that data on zelicapavir, an oral, once-daily, N-protein inhibitor, in development for the treatment of (RSV) have been accepted for two oral presentations at the European Society of Clinical Microbiology & Infectious Diseases Global 2026 (ESCMID) being held April 17-21...
Agiliti Introduces Capillaire™ — Low-Profile Alternating Pressure Overlay Clinically Proven to Prevent Perioperative Pressure Injuries
MINNEAPOLIS--(BUSINESS WIRE)--Agiliti, a leading manufacturer and provider of medical device solutions to the U.S. healthcare industry, today announced the launch of Capillaire™.
Pulse Biosciences Enrolls First Patients in NANOPULSE-AF IDE Pivotal Clinical Study Evaluating nPulse™ Cardiac Catheter System for Atrial Fibrillation
HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of nPulse™ technology using proprietary nanosecond pulsed field ablation (nsPFA™) energy, today announced enrollment of the first patients in its NANOPULSE-AF study, a prospective, multicenter, IDE pivotal clinical investigation currently evaluating the nPulse™ Cardiac Catheter System for treating recurrent, drug-resistant, symptomatic paroxysmal atrial fibrillation (AF). The first seven patients in this study w...
Bruker Invests in Photothermal AFM-IR to Advance Semiconductor Research
BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced accelerated development of its photothermal AFM-IR spectroscopy capabilities to address research challenges facing the semiconductor industry as device architectures continue to shrink and systems become increasingly more complex. As the largest supplier of nanoscale infrared (nanoIR) spectroscopy technology to the semiconductor industry, Bruker is expanding the use of AFM-IR beyond its established role in nano...
Bausch + Lomb Launches Preloaded enVista Envy™ Full Range of Vision Intraocular Lenses in Europe
VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced European commercial availability of the preloaded enVista Envy full range of vision intraocular lens (IOL), which offers excellent dysphotopsia tolerance on the widely used enVista IOL platform. “Bausch + Lomb now offers two full range of vision premium IOLs - enVista Envy and LuxLife™ to meet the evolving needs...
Redwire Expands European Footprint, Opens UK Office to Support Ministry of Defence Programs
LONDON--(BUSINESS WIRE)---- $RDW--Redwire Corporation (NYSE: RDW), a global leader in aerospace and defence technology solutions, today announced the company has opened an office in the United Kingdom to directly support current and future programs under the UK Ministry of Defence (MOD), ensuring best-in-class responsiveness, technical expertise, and an enduring partnership. Redwire's expanded UK presence will include dedicated staff across engineering, program management, logistics, and sustainment fun...
ReposiTrak Traceability Network Extends Deeper into the Food Supply Chain as 18 Fresh Fruit & Vegetable Providers Join the Queue Preparing for Traceability
SALT LAKE CITY--(BUSINESS WIRE)--ReposiTrak (NYSE:TRAK), the world's largest food traceability and regulatory compliance network, leveraging its established inventory management and out-of-stock reduction SaaS platform, announces the addition of eighteen fresh fruit and vegetable companies to the queue for the ReposiTrak Traceability Network. By joining the queue now, these companies are taking the first critical step toward efficiently exchanging FDA-required Key Data Elements (KDEs) for each...
ProCap Financial Launches ProCap Insights, the First Agentic Research Offering in Finance
NEW YORK--(BUSINESS WIRE)--ProCap Financial, Inc. (Nasdaq: BRR) (the “Company”), the first publicly traded agentic finance firm, today launched ProCap Insights, the first agentic research offering in finance. Leveraging the latest artificial intelligence technology, ProCap Insights delivers institutional-grade research to help independent investors make more informed investment decisions. Reports cover single-name stocks, thematic trends, and macro analysis across sectors and asset classes. Res...
Serve Robotics Debut Conversational Robot Powered by Edge AI at NVIDIA GTC 2026
SAN FRANCISCO, April 07, 2026 (GLOBE NEWSWIRE) -- Serve Robotics Inc. (Nasdaq: SERV), a leading autonomous robotics company, recently introduced “Maggie,” its first AI-powered conversational robot, during a live demonstration at NVIDIA GTC 2026. Maggie is designed to interact with humans in real time, marking a significant step toward more dynamic, human-centric AI systems operating in the physical world...
Fortrea Unveils Fortrea Intelligent Technology™ to Help Sponsors and Sites Run Smarter, More Integrated Trials
Highlights: Designed to transform clinical trial operations for sponsors, sites and study teams Persona driven, AI-powered solutions automate workflows and streamline oversight to help improve trial speed, predictability and quality Builds on Fortrea's flagship platform Xcellerate to deliver near-real-time, role-based insights DURHAM, N.C., April 07, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global clinical research organization (CRO), today unveiled Fortrea Intelligent Technology™(FIT), a suite of innovative technology solutions designed to transform clinical trial operations...
Climb Bio Announces FDA Fast Track Designation for Budoprutug for the Treatment of Primary Membranous Nephropathy
WELLESLEY HILLS, Mass., April 07, 2026 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), a clinical stage biotechnology company developing therapeutics for patients with immune-mediated diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to budoprutug, the company's investigational anti-CD19 monoclonal antibody, for the treatment of primary membranous nephropathy (pMN)—a rare kidney disease for which there are currently no FDA-approved treatments...
Breckenridge Distillery Introduces Honey Whiskey Crafted with Rare Nigerian Goldswarm Honey—A Must-Try for Whiskey Enthusiasts
BRECKENRIDGE, Colo., April 07, 2026 (GLOBE NEWSWIRE) -- Breckenridge Distillery, an award-winning craft distillery and spirits brand by Tilray Brands, Inc. (NASDAQ: TLRY; TSX: TLRY), announces the re-launch of Breckenridge Honey Whiskey, a bold new expression infused with Goldswarm Raw Honey from Nigeria...
TopBuild to Release First Quarter 2026 Results on Tuesday, May 5
DAYTONA BEACH, Fla., April 07, 2026 (GLOBE NEWSWIRE) -- TopBuild Corp. (NYSE:BLD), a leading installer of insulation and commercial roofing and a specialty distributor of insulation and related building material products to the construction industry in the United States and Canada, announced it will release its first quarter 2026 results prior to 7:00 a.m...
Autolus Therapeutics to Participate in Upcoming Investor Conferences
LONDON and GAITHERSBURG, Md., April 07, 2026 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, announced that the Company will participate in two upcoming investor conferences...
Emerita Announces Results of Airborne Electromagnetic and Magnetic Survey, Provides Update on Mineral Resources Estimate
TORONTO, April 07, 2026 (GLOBE NEWSWIRE) -- Emerita Resources Corp. (TSX-V: EMO; OTCQX: EMOTF; FSE: LLJA) (the “Company” or “Emerita”) has received the interpreted results from Helicopter time-domain electromagnetic and magnetic (HTEM) airborne geophysical surveying completed in December (see the Company's news release dated December 1, 2025). The survey covered 13,900 hectares over its mineral claims in the Iberian Belt West Project (“IBW” or the “Project”) area (Figure 1), covering the IBW property and the large adjacent San Antonio land package...
Asbury Automotive Group Schedules Release of First Quarter 2026 Financial Results
ATLANTA--(BUSINESS WIRE)--Asbury Automotive Group Schedules Release of First Quarter 2026 Financial Results.
Skye Bioscience Presenting at GLP-1-Based Therapeutics Summit
SAN DIEGO, April 07, 2026 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”) a clinical-stage biotechnology company focused on unlocking new therapeutic pathways for obesity and other metabolic health disorders, will present at the GLP-1-Based Therapeutics Summit in Boston, MA, being held April 14-16. Presentation Details Title: Maximizing Efficacy, Minimizing Risk by Leveraging Peripheral CB1 Antagonism in Combination with GLP-1 Agonists to Advance the Obesity Treatment Paradigm Presenter: Punit Dhillon, President & CEO Date: Thursday, April 16, 2026 Time: 1:30 pm About Nimacimab Nimacimab is a potential first-in-class, peripherally-restricted monoclonal antibody inhibitor of the CB1 receptor...
Nurix Therapeutics to Participate in Upcoming Investor Conference
BRISBANE, Calif., April 07, 2026 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines, today announced that Arthur Sands, M.D.
Sionna Therapeutics to Participate in the Raymond James 2026 Biotech Innovation Symposium
WALTHAM, Mass., April 07, 2026 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein, today announced that management will participate in one-on-one investor meetings at the Raymond James 2026 Biotech Innovation Symposium on Tuesday, April 14th, 2026...
PowerBank Announces $1.1 Million USD Incentive from NYSERDA for 7.1 MW Solar Project in New York
Incentive payment awarded under the NYSERDA's NY-Sun Program Project expected to provide clean energy to the equivalent of 895 homes annually This news release constitutes a "designated news release" for the purposes of the Company's prospectus supplement dated February 17, 2026 to its short form base shelf prospectus dated May 7, 2025. TORONTO, April 7, 2026 /PRNewswire/ - PowerBank Corporation (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: 103) ("PowerBank" or the "Company), a leader in distributed solar energy, battery storage, and clean energy infrastructure across North America, is pleased to announce that its 7.1 MW Jordan Rd 2 community solar project (the "Project") located on privately-owned brownfield lands in Skaneateles Falls, New York has been approved for up to $1,119,618 USD in incentives through the New York State Energy Research and Development Authority (NYSERDA) NY-Sun Program...
Enthusiast Gaming Announces Receipt of MCTO
Toronto, Ontario--(Newsfile Corp. - April 7, 2026) - Enthusiast Gaming Holdings Inc. (TSX: EGLX) ("Enthusiast Gaming" or the "Company"), a leading digital publisher focused on building tools, platforms, and experiences for gamers, today announced that further to its news release dated March 31, 2026, regarding the Company's application to the Ontario Securities Commission ("OSC") for a management cease trade order ("MCTO") to be imposed in respect of its delay in filing its annual financial statements, management's discussion and analysis, annual information form and related officer certifications for the financial year ended December 31, 2025 (collectively, the "Annual Filings"), the OSC has granted the MCTO. The MCTO does not affect the ability of shareholders who are not employees or insiders of the Company to trade their securities of the Company...
SuperQ Quantum Joins Quantum Security Defence to Enable Quantum-Resilient Infrastructure for Impending PQC Transition
Calgary, Alberta--(Newsfile Corp. - April 7, 2026) - SuperQ Quantum Computing Inc. (CSE: QBTQ) (OTCQB: QBTQF) (FSE: 25X) ("SuperQ Quantum", "SuperQ", or the "Company"), a leader in sovereign quantum-safe infrastructure and AI-orchestrated cybersecurity, today announced it has joined forces with Quantum Security Defence (QSECDEF). This move integrates SuperQ into an elite ecosystem dedicated to addressing the rapidly escalating threats to global data sovereignty and national security...
Wayfair Announces First Florida Store in Fort Lauderdale, Opening in 2027
New location at Galleria Fort Lauderdale will be part of the center's major redevelopment BOSTON, April 7, 2026 /PRNewswire/ -- Wayfair Inc. (NYSE: W), the destination for all things home, today announced it will open its first large-format store in Florida at Galleria Fort Lauderdale, as part of the center's comprehensive redevelopment. Scheduled to open in late 2027, the new location will span approximately 94,000 square feet across two levels, marking a significant milestone in Wayfair's continued physical retail expansion...
Abitibi Metals Expands Western Down-Plunge Zone with 150m Step-Out, Intersecting 2.71% CuEq over 7m within 1.81% CuEq over 15m
Highlights: Significant intercept confirms growth of the high-grade western down-plunge zone: Hole 1274-25-373W4 intersected 1.81% CuEq over 15 m starting at 1,346 m depth, including a higher-grade interval of 2.71% CuEq (1.88% Cu, 0.56 g/t Au) over 7m, with a peak of 4.52% CuEq over 2m. Confirms robust continuity within an expanding high-grade mineralized system along the Western Plunge...
Cyber Enviro-Tech Inc Expands Board with AirPower CEO, Strengthens Leadership and Advances $200M+ Clean Energy Opportunities
SCOTTSDALE, Ariz., April 7, 2026 /PRNewswire/ -- Cyber Enviro-Tech, Inc. (OTCQB: CETI), an environmental technology company focused on sustainable solutions across water treatment and clean energy, today announced strategic enhancements to its Board of Directors and continued progress in advancing its global clean energy initiatives...
Creator TV Launches "Creator Pickleball Tour" at VidCon Anaheim in Partnership with Viewws
Three-day fan activation and televised creator tournament introduces a new live programming format under Creator TV Sports TORONTO, April 7, 2026 /PRNewswire/ -- Sabio Holdings (TSXV: SBIO) (OTCQB: SABOF) (the "Company" or "Sabio"), a Los Angeles-based ad-tech company helping top global brands reach, engage, and validate (R.E.V.) streaming TV audiences today announced that Creator TV will launch the Creator Pickleball Tour, a new live event and competition format under its Creator TV Sports label...
A2Z Receives Notice from Nasdaq Confirming Compliance with Annual Meeting Requirement
TORONTO, April 7, 2026 /PRNewswire/ - A2Z Cust2Mate Solutions Corp. (NASDAQ: AZ), a global leader in smart retail technology, today announced that the Company received formal notice from the Nasdaq Stock Market LLC ("Nasdaq") that the Company has regained compliance with the annual meeting requirement for continued listing set forth in Nasdaq's Listing Rule 5620. About A2Z Cust2Mate Solutions Corp. A2Z Cust2Mate Solutions Corp. (NASDAQ: AZ) makes in-store retail smarter by connecting retailers, brands, and shoppers at the Smart Cart...
Notice of BetMGM 1Q 2026 Update and Conference Call
JERSEY CITY, N.J., April 7, 2026 /PRNewswire/ -- BetMGM LLC ("BetMGM"), a leading sports betting and iGaming operator across North America, jointly owned by MGM Resorts International (NYSE: MGM) ("MGM Resorts") and Entain plc (LSE: ENT), will release a business update for the period January 1 – March 31, 2026 ("1Q") on Tuesday April 14, 2026 at 7:00am ET (4:00am PT / 12:00pm UK)...
MAYFAIR BOLSTERS EXECUTIVE TEAM WITH ADDITION OF VETERAN CFO
VANCOUVER, BC, April 7, 2026 /PRNewswire/ - Mayfair Gold Corp. ("Mayfair", "Mayfair Gold" or the "Company") (NYSE American: MINE; TSX-V: MFG) is pleased to announce the appointment of Kevin Annett as Chief Financial Officer of the Company ("CFO"), effective April 7, 2026. Kevin Annett, CPA, is a seasoned mining finance executive with over 15 years of experience spanning project construction, operations, and corporate leadership...
BOARDWALK REIT PROVIDES OPERATIONAL AND CAPITAL ALLOCATION UPDATE AND ANNOUNCES TIMING OF FIRST QUARTER RESULTS
CALGARY, AB, April 7, 2026 /PRNewswire/ - Boardwalk Real Estate Investment Trust - (TSX: BEI.UN) Boardwalk REIT ("Boardwalk", "the Trust", "We", "Our") is providing an update highlighting its recent leasing performance and capital allocation initiatives. Sam Kolias, Chairman and Chief Executive Officer commented: "As we enter our spring leasing season with occupancy above 97%, our team remains focused on providing the best service, quality and experience to our Resident Family Members...
MediWound to Present New EscharEx® Data at Leading Wound Care Conferences
MediWound to Present New EscharEx Data at Leading Wound Care Conferences Data highlights mechanism of action, outcomes in VLUs and DFUs, and comparative advantages over SANTYL Findings support ongoing VALUE Phase III study and planned expansion into DFUs and pressure ulcers YAVNE, Israel, April 7, 2026 (GLOBE NEWSWIRE) — MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced multiple oral and poster presentations at three leading wound care conferences: the Wound Healing Society (WHS) and the Symposium on Advanced Wound Care (SAWC) Spring 2026, taking place April 8–12 in Charlotte, North Carolina, and the European Wound Management Association (EWMA) 2026, taking place May 6–8 in Bremen, Germany...
Plug Participating in RBC Non-Deal Roadshow in Canada
SLINGERLANDS, N.Y., April 07, 2026 (GLOBE NEWSWIRE) -- Plug Power Inc. (NASDAQ: PLUG), a global leader in comprehensive solutions for the hydrogen economy, will participate in a non-deal roadshow hosted by RBC. The meetings will provide an opportunity for institutional investors to engage with management on Plug's business strategy, operational execution, and path to profitability...
Generac and CPower Expand Access to DER Technologies to Support Resiliency, Energy Costs and Grid Capacity
The collaboration combines Generac's industry-leading DER solutions platform with CPower's industry-leading VPP/DR services, creating a first-to-market solution to support customers in North America's largest electricity market. WAUKESHA, Wis.
Generac and CPower Expand Access to DER Technologies to Support Resiliency, Energy Costs and Grid Capacity
The collaboration combines Generac's industry-leading DER solutions platform with CPower's industry-leading VPP/DR services, creating a first-to-market solution to support customers in North America's largest electricity market. WAUKESHA, Wis.
Stepan to Announce First Quarter 2026 Results on April 28, 2026
NORTHBROOK, Ill., April 7, 2026 /PRNewswire/ -- Stepan Company (NYSE: SCL) will issue its first quarter 2026 earnings results on Tuesday, April 28, 2026 at approximately 7:00 a.m.
Artivion Announces U.S. FDA Approval of the NEXUS® Aortic Arch System
Endospan's NEXUS branched endovascular stent graft system shown to effectively treat aortic arch disease, including chronic aortic dissections ATLANTA, April 7, 2026 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that the U.S. Food and Drug Administration (FDA) has approved the premarket approval application (PMA) for the NEXUS Aortic Arch System, developed by Endospan Ltd. ("Endospan"), Artivion's long-standing partner...
Jin Medical International Ltd. Has Regained Compliance with Nasdaq's Minimum Bid Price Requirement
CHANGZHOU, China, April 7, 2026 /PRNewswire/ -- Jin Medical International Ltd. (NASDAQ: ZJYL) ("Jin Medical", and together with all its subsidiaries and consolidated entities, the "Company"), a NASDAQ-listed leading provider of rehabilitation medical equipment, today announced that it has received written notification from the Nasdaq Listing Qualifications Department of The Nasdaq Stock Market LLC confirming that the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2), the minimum bid price requirement...
Ascletis Announces Fixed-Dose Combination of ASC30, Once-Daily Oral Small Molecule GLP-1R Agonist, and ASC39, Once-Daily Oral Small Molecule Amylin-Selective Amylin Receptor Agonist, for Clinical Development
-Fixed - dose combination of ASC30 and ASC39 (ASC30_39 FDC) tablets, dosed orally in dogs, demonstrated comparable pharmacokinetics to those observed in their respective monotherapies in a head-to-head study . The fixed dose combination had excellent oral bioavailability, drug exposure and a half -life of up to 12 hours...
Atlas Energy Solutions Inc. Announces Pricing of Upsized $390 Million Private Placement of 0.50% Convertible Senior Notes Due 2031
AUSTIN, Texas--(BUSINESS WIRE)--Atlas Energy Solutions Inc. (NYSE: AESI) (together with its subsidiaries, “Atlas” or the “Company”) today announced that it has priced its previously announced private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”) of $390 million aggregate principal amount of 0.50% Convertible Senior Notes due 2031 (the “notes”). The size of the offering was in...
Highlander Silver Provides Update; Drilling Commences at Corani Silver Project
TORONTO, April 07, 2026 (GLOBE NEWSWIRE) -- Highlander Silver Corp. (TSX, NYSE American: HSLV) (“Highlander Silver” or the “Company”) is pleased to provide a portfolio update following the successful completion of its combination with Bear Creek Mining (see press release dated February 26, 2026). Daniel Earle, President and CEO of Highlander Silver, commented: “Highlander Silver is well positioned to fast-track project advancement across its portfolio of high-quality silver assets...
Paysafe launches Pay with Crypto solution to meet US iGaming market demand
LONDON--(BUSINESS WIRE)--Paysafe (NYSE: PSFE), a global payments platform, today announced the launch of Pay with Crypto, a new crypto payment method for iGaming operators and daily fantasy sports brands in the U.S. market. Powered by MoonPay, the leader in global crypto payments and stablecoin infrastructure, Pay with Crypto allows iGaming brands' customers to use their preferred stablecoin or cryptocurrency to effortlessly fund their player accounts, where permitted. With a reported ~70.4m Am...
FOX to Integrate Kalshi Forecasts Across FOX News Media and FOX One Platforms
NEW YORK--(BUSINESS WIRE)--Kalshi, the world's largest prediction market, and Fox Corporation (NASDAQ: FOXA, FOX), a leader in producing and distributing news, sports and entertainment content, today announced an integration to incorporate Kalshi's data across FOX News Channel, FOX Business Network, FOX Weather and the FOX One platform. Prediction markets harness the power of the wisdom of the crowds, creating data that can effectively complement polling and expert opinion. Kalshi data has been...
Pembina Business Update Highlights Strategic Focus and Growth Outlook
CALGARY, Alberta--(BUSINESS WIRE)--Pembina Pipeline Corporation ("Pembina" or "the Company") (TSX: PPL; NYSE: PBA) will hold a webcast and conference call on Tuesday, April 7, 2026, at 8:00 a.m. MT (10:00 a.m. ET). During the call, Pembina's officer team will present a business update that reaffirms the Company's longstanding commitment to disciplined execution; outlines the 3Cs Strategy - Capture, Connect, and Catalyze; and provides a financial outlook to the end of the decade, including 5-7 p...
Accel Entertainment, Inc. to Report First Quarter 2026 Results, Host Conference Call and Webcast on May 5
CHICAGO--(BUSINESS WIRE)--Accel Entertainment, Inc. (NYSE: ACEL) (“Accel” or “the Company”), a leading locals-focused gaming operator partnering with small businesses, local communities, and state governments to provide entertaining, convenient, and safe gaming experiences nationwide, announced today it will release its financial and operating results for the first quarter ended March 31, 2026, after market close on Tuesday, May 5, 2026. The Company will host a conference call and webcast that...
Clough Global Opportunities Fund Declares Monthly Distributions for April, May, and June 2026 of $0.0537 Per Share
DENVER, CO / ACCESS Newswire / April 7, 2026 / Today, Clough Global Opportunities Fund (NYSE American:GLO) (the "Fund") declared monthly cash distributions of $0.0537 per common share, payable on the dates noted below. The Fund's managed distribution policy is intended to provide shareholders with a consistent monthly distribution at a rate of at least one-twelfth of 10% of the Fund's average net asset value ("NAV") per share for the last five business days of the prior calendar year...
Clough Global Equity Fund Declares Monthly Distributions for April, May, and June 2026 of $0.0729 per Share
DENVER, CO / ACCESS Newswire / April 7, 2026 / Today, Clough Global Equity Fund (NYSE American:GLQ) (the "Fund") declared monthly cash distributions of $0.0729 per common share, payable on the dates noted below. The Fund's managed distribution policy is intended to provide shareholders with a consistent monthly distribution at a rate of at least one-twelfth of 10% of the Fund's average net asset value ("NAV") per share for the last five business days of the prior calendar year...
Reaves Utility Income Fund Announces Regular Monthly Distributions of $0.20 Per Share
DENVER, CO / ACCESS Newswire / April 7, 2026 / Reaves Utility Income Fund (NYSE American:UTG) announced today the next three, monthly, distributions at a rate of $0.20 per common share per month, unchanged from the per share rate paid for the previous quarter. As of April 1, 2026, the Fund's market price was $39.77 per share and its net asset value was $39.62 per share...
Fury Appoints Vice President, Project Development
TORONTO, April 07, 2026 (GLOBE NEWSWIRE) -- Fury Gold Mines Limited (TSX and NYSE American: FURY) (“Fury” or the “Company”) is pleased to announce the appointment of Mario Courchesne as Vice President, Project Development, effective immediately.
Northisle Announces Expansion of Executive and Technical Advisory Team
VANCOUVER, British Columbia--(BUSINESS WIRE)---- $NCX #bc--Northisle is pleased to announce several additions to its leadership team.
Consensus Cloud Solutions to Host Q1 2026 Investor Call on May 7, 2026
LOS ANGELES--(BUSINESS WIRE)--Consensus Cloud Solutions, Inc., (NASDAQ: CCSI), invites the public, members of the press, the financial community, and other interested parties to listen to a live audio Webcast of its Q1 2026 earnings call at 2:00 PM PT/5:00 PM ET on Thursday, May 7th, 2026. Consensus Cloud Solutions' Chief Executive Officer, Scott Turicchi, Chief Revenue Officer, Johnny Hecker, and Chief Financial Officer, Adam Varon will host the call to discuss Q1 2026 financial results, provi...
YieldMax® ETFs Announces Distributions on BIGY, RNTY and SOXY
CHICAGO and MILWAUKEE and NEW YORK, April 07, 2026 (GLOBE NEWSWIRE) -- YieldMax today announced distributions for the YieldMax Target 12™ ETFs listed in the table below. The Fund seeks to generate income with a 12% target annual income level.
YieldMax® ETFs Announces Weekly Distributions for Group 1 ETFs
CHICAGO and MILWAUKEE and NEW YORK, April 07, 2026 (GLOBE NEWSWIRE) -- YieldMax ETFs announced distributions for the YieldMax Group 1 weekly pay ETFs. Group 1 Distribution Announcement Ex.
Golar LNG Limited – Q1 2026 results presentation
Golar LNG's 1st Quarter 2026 results will be released before the market opens on Wednesday, May 20, 2026. In connection with this a webcast presentation will be held at 08:00am Eastern Time (1:00pm London Time) on Wednesday May 20, 2026. The presentation will be available to download from the Investor Relations section at www.golarlng.com
ANI Pharmaceuticals Announces Publication of NEW DAY Clinical Trial Results in Ophthalmology
PRINCETON, N.J., April 07, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced publication of the results from the NEW DAY clinical trial involving ILUVIEN (fluocinolone acetonide intravitreal implant), 0.19 mg (ILUVIEN) for use in appropriate patients with diabetic macular edema in Ophthalmology, the journal of the American Academy of Ophthalmology. The company previously announced results from the NEW DAY trial in July 2025. ILUVIEN is a corticosteroid indicated for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure...